Literature DB >> 3232542

Behavioral assessment of patients treated with alpha-interferon.

A Niiranen1, R Laaksonen, M Iivanainen, K Mattson, M Färkkilä, K Cantell.   

Abstract

To document behavioral effects of interferon (IFN) with daily consecutive assessments we developed an easily administered procedure for bedside testing. It included assessment of mental control and affective behavior, and a self-assessment questionnaire. The method was evaluated in 9 lung cancer patients before and during the treatment with alpha-IFN and the results were supplemented with those obtained by a neuropsychological test battery of one of the patients. The latter tests covered memory, visuoperceptual, visuoconstructional, speech, language, intellectual and psychomotor functions, reading, writing, and calculation. The bedside method was capable of revealing the essential effects of IFN on human behavior, i.e. irritability, slowing of behavior, dyscoordination, and motor perseveration. Consequently, the bedside testing method is recommended for frequently repeated clinical assessments of aberrant behavior of patients treated with IFN, while neuropsychological test batteries serve better for testing situations requiring more detailed and quantified data of localization value.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3232542     DOI: 10.1111/j.1600-0447.1988.tb06395.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health.

Authors:  Angela J Grippo
Journal:  Soc Personal Psychol Compass       Date:  2011-04

2.  The possibility of the use of interferon in the treatment of alcoholism.

Authors:  N A Aliev; M A Mustafaev
Journal:  Neurosci Behav Physiol       Date:  1993 Jul-Aug

Review 3.  Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

Authors:  Charles L Raison; Marina Demetrashvili; Lucile Capuron; Andrew H Miller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Toll-Like Receptor Signaling in Depression.

Authors:  Leandra K Figueroa-Hall; Martin P Paulus; Jonathan Savitz
Journal:  Psychoneuroendocrinology       Date:  2020-09-01       Impact factor: 4.905

Review 5.  Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models.

Authors:  Angela J Grippo; Alan Kim Johnson
Journal:  Stress       Date:  2009-01       Impact factor: 3.493

Review 6.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 7.  Neuropsychiatric disorders related to interferon and interleukins treatment.

Authors:  Aye Mu Myint; Markus J Schwarz; Harry W M Steinbusch; Brian E Leonard
Journal:  Metab Brain Dis       Date:  2008-12-10       Impact factor: 3.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.